BioWorld MedTech

July 15, 2015

DragonBio's remaining stake worth $73 million: Mindray finishes what it started with acquisition of remaining stake in Dragonbio

HONG KONG — Chinese medical device maker, Mindray Medical (Shenzhen) will acquire for $72.6 million the remaining 49% stake in Dragonbio Surgical Implant (Wuhan, China) that it did not acquire in an earlier deal. Read More

Inside the Beltway: FDA applies revised USP standards to draft guidance for heparin-bearing products

European TechTour Summit: Med-tech becoming increasingly 'personal' as technology improves

Attitude Adjustment needed: Beltway attitude change needed to spur biomedical investment

New Trade Association: Association forms to help smaller device firms promote value-based solutions

Financings: Opgen closes $6M funding headed up by Merck GHI

World in Review: Danish cancer center first in Europe to use Varian's Calypso transponders

Agreements/contracts: Multiple company collaboration to fight Type 2 diabetes battle

Briefly Noted

Products

People in Places

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 22, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 22, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...